Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$683K Sell
2,427
-12
-0.5% -$3.02K 0.25% 43
2026
Q1
$591K Buy
2,439
+2
+0.1% +$541 0.25% 42
2025
Q4
$722K Buy
2,437
+1
+0% +$299 0.3% 40
2025
Q3
$687K Sell
2,436
-231
-9% -$60.5K 0.3% 39
2025
Q2
$786K Sell
2,667
-64
-2% -$16.5K 0.35% 40
2025
Q1
$679K Buy
2,731
+1
+0% +$245 0.32% 42
2024
Q4
$600K Buy
2,730
+2
+0.1% +$445 0.3% 42
2024
Q3
$603K Sell
2,728
-223
-8% -$43.7K 0.3% 44
2024
Q2
$510K Buy
2,951
+2
+0.1% +$348 0.27% 44
2024
Q1
$563K Buy
2,949
+2
+0.1% +$365 0.3% 43
2023
Q4
$482K Buy
2,947
+15
+0.5% +$2.27K 0.28% 42
2023
Q3
$411K Buy
2,932
+17
+0.6% +$2.42K 0.27% 43
2023
Q2
$390K Sell
2,915
-997
-25% -$129K 0.25% 42
2023
Q1
$513K Buy
3,912
+136
+4% +$18.2K 0.36% 38
2022
Q4
$532K Buy
+3,776
New +$521K 0.42% 35

Other funds holding IBM

MB, Levis & Associates's IBM Position: Q2 2026 in Review

MB, Levis & Associates reduced its IBM (IBM) stake by 0.49% in Q2 2026, selling an estimated $3.02K and leaving 2,427 shares worth $683K. The position accounts for 0.25% of the portfolio, ranked #43.

MB, Levis & Associates first reported a position in IBM in Q4 2022 and has held it in 15 quarters since. The position peaked at $786K in Q2 2025. 1,915 funds tracked by Wall St. Rank hold IBM as of Q2 2026.

  • MB, Levis & Associates held 2,427 shares of IBM worth $683K as of Q2 2026.
  • MB, Levis & Associates sold 12 IBM shares in Q2 2026, an estimated $3.02K.
  • IBM made up 0.25% of MB, Levis & Associates's portfolio in Q2 2026, its #43 holding.
  • MB, Levis & Associates first reported a position in IBM in Q4 2022 and has held it in 15 quarters since.
  • MB, Levis & Associates's IBM position peaked at $786K in Q2 2025.
  • 1,915 funds tracked by Wall St. Rank held IBM as of Q2 2026.

Based on MB, Levis & Associates's 13F filing for Q2 2026, filed 22 Jul 2026.